Investigation into the effect of varying l -leucine concentration on the product characteristics of spray-dried liposome powders

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 10, 2012, Pages 1412-1424

  Chen, Kun Hung ^a   Mueannoom, Wunlapa ^b   Gaisford, Simon ^b   Kett, Vicky L ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

disaccharide; leucine; liposomes; spray drying

Indexed keywords

INDOMETACIN; LEUCINE; LIPOSOME; SUCROSE; TREHALOSE;

ARTICLE; CHEMICAL PARAMETERS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPOSOMAL DELIVERY; PARTICLE SIZE; POLYDISPERSITY; POWDER; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; THERMAL ANALYSIS; WATER CONTENT;

DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EXCIPIENTS; INDOMETHACIN; LEUCINE; LIPOSOMES; LUNG; PARTICLE SIZE; POWDERS; SUCROSE; TREHALOSE;

EID: 84865864655     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01521.x     Document Type: Article

References (60)

1. Mccullough HN, Juliano RL,. Organ-selective action of an anti-tumor drug-pharmacologic studies of liposome-encapsulated beta-cytosine arabinoside administered via the respiratory system of the rat. J Natl Cancer Inst 1979; 3: 727-731. (Pubitemid 10225000)
2. McCalden TA, et al,. Bronchodilator efficacy of liposome formulations of metaproterenol sulfate in the anesthetized guinea pig. J Liposome Res 1989; 2: 211-222. (Pubitemid 19270415)
3. Taylor KMG, et al,. The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man. Pharm Res 1989; 7: 633-636. (Pubitemid 19214431)
4. Wong JP, et al,. Liposome delivery of ciprofloxacin against intracellular francisella tularensis infection. J Control Release 2003; 3: 265-273. (Pubitemid 38366150)
5. Ferro S, et al,. Efficient photoinactivation of methicillin-resistant staphylococcus aureus by a novel porphyrin incorporated into a poly-cationic liposome. Int J Biochem Cell Biol 2007; 5: 1026-1034. (Pubitemid 46575332)
6. Guo WJ, et al,. Characterization of a novel diolein-based LPDII vector for gene delivery. J Control Release 2002; 1: 121-132.
7. Igarashi S, et al,. Biosurfactant mel-a enhances cellular association and gene transfection by cationic liposome. J Control Release 2006; 3: 362-368. (Pubitemid 43737151)
8. Maitani Y, et al,. Cationic liposome (dc-chol/dope = 1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression. Int J Pharm 2007; 1-2: 33-39. (Pubitemid 47259323)
9. Cryan SA,. Carrier-based strategies for targeting protein and peptide drugs to the lungs. AAPS J 2005; 1: E20-E41.
10. Zeng XM, et al,. The controlled delivery of drugs to the lung. Int J Pharm 1995; 2: 149-164.
11. Bangham AD, et al,. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238-252.
12. Batzri S, Korn ED,. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 1973; 4: 1015-1019.
13. Szoka F, Papahadjopoulos D,. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 1978; 9: 4194-4198. (Pubitemid 9025976)
14. Kirby CJ, Gregoriadis G,. Preparation of liposomes containing factor viii for oral treatment of haemophilia. J Microencapsul 1984; 1: 33-45.
15. Naeff R,. Feasibility of topical liposome drugs produced on an industrial scale. Adv Drug Deliv Rev 1996; 3: 343-347.
16. Both DM, et al,. Liposome-encapsulated ursolic acid increases ceramides and collagen in human skin cells. Arch Dermatol Res 2002; 11: 569-575. (Pubitemid 34151128)
17. Wagner A, et al,. Liposomes produced in a pilot scale: production, purification and efficiency aspects. Eur J Pharm Biopharm 2002; 2: 213-219. (Pubitemid 34919396)
18. Elzainy AAW, et al,. Hydroxyzine from topical phospholipid liposomal formulations: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model. AAPS PharmSci 2003; 4: E28.
19. Stano P, et al,. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method. J Liposome Res 2004; 1-2: 87-109. (Pubitemid 39310573)
20. Justo OR, Moraes AM,. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment. J Pharm Pharmacol 2005; 1: 23-30. (Pubitemid 40030098)
21. Ugwu S, et al,. Preparation, characterization, and stability of liposome-based formulations of mitoxantrone. Drug Dev Ind Pharm 2005; 2: 223-229. (Pubitemid 40315717)
22. Zhong HJ, et al,. Multivesicular liposome formulation for the sustained delivery of breviscapine. Int J Pharm 2005; 1-2: 15-24.
23. Padamwar MN, Pokharkar VB,. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Int J Pharm 2006; 1-2: 37-44. (Pubitemid 44128702)
24. Wang Z, et al,. Development and pharmacokinetics of nimodipine-loaded liposomes. J Pharm Pharmacol 2006; 9: 1289-1294. (Pubitemid 44329112)
25. Jaafar-Maalej C, et al,. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res 2010; 3: 228-243.
26. Perrett S, et al,. A simple method for the preparation of liposomes for pharmaceutical applications-characterization of the liposomes. J Pharm Pharmacol 1991; 3: 154-161.
27. Turanek J, et al,. Linkup of a fast protein liquid chromatography system with a stirred thermostated cell for sterile preparation of liposomes by the proliposome-liposome method: application to encapsulation of antibiotics, synthetic peptide immunomodulators, and a photosensitizer. Anal Biochem 1997; 2: 131-139.
28. Pavelic Z, et al,. Liposomes containing drugs for treatment of vaginal infections. Eur J Pharm Sci 1999; 4: 345-351. (Pubitemid 29325027)
29. Rengel RG, et al,. High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes. Eur J Pharm Sci 2002; 5: 441-448.
30. Ishikawa H, et al,. Liposomal microcapsulation of enzymes by proliposome method with chitosan-coating. J Fac Agric Kyushu Univ 2005; 1: 141-149. (Pubitemid 40374573)
31. Elhissi AMA, et al,. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers. J Pharm Pharmacol 2006; 7: 887-894. (Pubitemid 43967104)
32. Hauser H, Strauss G,. Stabilization of small unilamellar phospholipid-vesicles during spray-drying. Biochim Biophys Acta 1987; 2: 331-334. (Pubitemid 17038878)
33. Goldbach P, et al,. Spray-drying of liposomes for a pulmonary administration. 1. Chemical-stability of phospholipids. Drug Dev Ind Pharm 1993; 19: 2611-2622. (Pubitemid 23337907)
34. Lo YL, et al,. Liposomes and disaccharides as carriers in spray-dried powder formulations of superoxide dismutase. J Control Release 2004; 2-3: 259-272.
35. Seville PC, et al,. Amino acid-modified spray-dried powders with enhanced aerosolisation properties for pulmonary drug delivery. Powder Technol 2007; 1: 40-50. (Pubitemid 47247802)
36. Lechuga-Ballesteros D, et al,. Trileucine improves aerosol performance and stability of spray-dried powders for inhalation. J Pharm Sci 2008; 1: 287-302.
37. Arakawa T, et al,. Biotechnology applications of amino acids in protein purification and formulations. Amino Acids 2007; 4: 587-605. (Pubitemid 350165440)
38. Lucas P, et al,. Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive. Pharm Res 1999; 10: 1643-1647. (Pubitemid 29510566)
39. Chew NYK, et al,. Effect of amino acids on the dispersion of disodium cromoglycate powders. J Pharm Sci 2005; 10: 2289-2300. (Pubitemid 41665288)
40. Oradd G, et al,. Effects of peptide hydrophobicity on its incorporation in phospholipid membranes-an nmr and ellipsometry study. Biochim Biophys Acta 2011; 1: 244-252.
41. Chougule M, et al,. Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics. Int J Nanomedicine 2007; 4: 675-688.
42. Chougule M, et al,. Development of spray dried liposomal dry powder inhaler of dapsone. AAPS PharmSciTech 2008; 1: 47-53.
43. Puglia C, et al,. Evaluation of in-vivo topical anti-inflammatory activity of indometacin from liposomal vesicles. J Pharm Pharmacol 2004; 10: 1225-1232. (Pubitemid 39368992)
44. Bligh EG, Dyer WJ,. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 8: 911-917.
45. Stewart JCM,. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 1980; 1: 10-14. (Pubitemid 10045896)
46. Dalpiaz A, et al,. Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. Biomaterials 2005; 11: 1299-1306. (Pubitemid 39314504)
47. Minne A, et al,. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients. Eur J Pharm Biopharm 2008; 3: 839-844.
48. Abdelwahed W, et al,. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm 2006; 2: 87-94. (Pubitemid 43776204)
49. Crowe JH, Crowe LM,. Factors affecting the stability of dry liposomes. Biochim Biophys Acta 1988; 2: 327-334. (Pubitemid 18088781)
50. Hatley RH,. Glass fragility and the stability of pharmaceutical preparations-excipient selection. Pharm Dev Technol 1997; 3: 257-264. (Pubitemid 28252521)
51. Maury M, et al,. Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray-dryer. Eur J Pharm Biopharm 2005; 3: 565-573. (Pubitemid 40342530)
52. Anchordoguy T, et al,. Mechanisms of interaction of amino-acids with phospholipid-bilayers during freezing. Biochim Biophys Acta 1988; 2: 299-306. (Pubitemid 19011355)
53. Popova AV, et al,. Differential destabilization of membranes by tryptophan and phenylalanine during freezing: the roles of lipid composition and membrane fusion. Biochim Biophys Acta 2002; 1: 109-118. (Pubitemid 34442249)
54. Mohammed AR, et al,. Amino acids as cryoprotectants for liposomal delivery systems. Eur J Pharm Sci 2007; 5: 406-413. (Pubitemid 46436456)
55. Rodriguez RB, Xamani MS,. Liposomes prepared by high-pressure homogenizers. Methods Enzymol 2003; 367: 28-46.
56. Zadi B, Gregoriadis G,. A novel method for high-yield entrapment of solutes into small liposomes. J Liposome Res 2000; 1: 73-80. (Pubitemid 30212619)
57. Foldvari M, et al,. Topical liposomal local-anesthetics-design, optimization and evaluation of formulations. Drug Dev Ind Pharm 1993; 19: 2499-2517. (Pubitemid 23337901)
58. You Y, et al,. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method. J Pharm Pharmacol 2007; 7: 927-934. (Pubitemid 47051072)
59. Bosquillon C, et al,. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Control Release 2001; 3: 329-339. (Pubitemid 32155456)
60. Adler M, et al,. Surface composition of spray-dried particles of bovine serum albumin/trehalose/surfactant. Pharm Res 2000; 7: 863-870. (Pubitemid 30666969)